1. 943PDResponse to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment. (23rd October 2018) Authors: Clamp, A R; McNeish, I A; Dean, A; Gallardo-Rincon, D; Kim, J-W; O'Donnell, D M; Hook, J; Blagden, S; Brenton, J D; Naik, R; Perren, T J; Sundar, S; Cook, A D; James, E C; Gabra, H; Lord, R; Hall, M; Dark, G; Kaplan, R S; Ledermann, J A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gene transfer: Bax to the future for cancer therapy. Issue 4 (11th March 2004) Authors: Lemoine, N R; McNeish, I A Journal: Gut Issue: Volume 53:Issue 4(2004) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗